Esperion Therapeutics Inc (NASDAQ:ESPR) shares, rose in value on Wednesday, April 16, with the stock price down by -3.19% to the previous day’s close as strong demand from buyers drove the stock to $0.96.
Actively observing the price movement in the last trading, the stock closed the session at $1.00, falling within a range of $0.9457 and $1.0. The value of beta (5-year monthly) was 0.861. Referring to stock’s 52-week performance, its high was $3.94, and the low was $0.93. On the whole, ESPR has fluctuated by -38.99% over the past month.
With the market capitalization of Esperion Therapeutics Inc currently standing at about $190.71 million, investors are eagerly awaiting this quarter’s results, scheduled for on 2025-Mar-03.
Projections by analysts suggest varying estimates for the company’s quarterly revenue. Analysts have estimated the company’s revenue for the quarter at 343.19M, with a low estimate of 44.4M and a high estimate of 63.8M. Wall Street analysts also predicted that the company’s y-o-y revenues would reach 54.97M.
Technical indicators serve as essential tools for traders, offering insights into market sentiment and potential price movements. We see that ESPR’s technical picture suggests that short-term indicators denote the stock is a 100% Sell on average. However, medium-term indicators have put the stock in the category of 100% Sell while long-term indicators on average have been pointing out that it is a 100% Sell.
The stock’s technical analysis shows that the price of ESPR currently trading nearly -27.19% and -38.26% away from the simple moving averages for 20 and 50 days respectively. The Relative Strength Index (RSI, 14) currently indicates a reading of 23.20, while the 7-day volatility ratio is showing 8.15% which for the 30-day chart, stands at 7.90%. Furthermore, Esperion Therapeutics Inc (ESPR)’s beta value is 0.80, and its average true range (ATR) is 0.10.
A comparison of Esperion Therapeutics Inc (ESPR) with its peers suggests the former has fared considerably weaker in the market. ESPR showed an intraday change of -3.19% in last session, and over the past year, it shrunk by -50.19%%.
Data on historical trading for Esperion Therapeutics Inc (NASDAQ:ESPR) indicates that the trading volumes over the past 10 days have averaged 6.95 and over the past 3 months, they’ve averaged 4.60 million. According to company’s latest data on outstanding shares, there are 195.85 million shares outstanding.
Nearly 1.76% of Esperion Therapeutics Inc’s shares belong to company insiders and institutional investors own 58.80% of the company’s shares. The data on short interest also indicates that stock shorts accounted for 28.02 million shares as on 2025-03-31, resulting in a short ratio of 6.23. According to the data, the short interest in Esperion Therapeutics Inc (ESPR) stood at 1420.00 of shares outstanding as of 2025-03-31; the number of short shares registered in 2025-02-28 reached 29.14 million. The stock has fallen by -56.19% since the beginning of the year, thereby showing the potential of a further growth. This could raise investors’ confidence to be optimistic about the ESPR stock heading into the next quarter.
